DreamCIS, Inc. Stock

Equities

A223250

KR7223250002

Healthcare Facilities & Services

End-of-day quote Korea S.E. 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
2,730 KRW +2.25% Intraday chart for DreamCIS, Inc. -3.19% -16.13%
Sales 2022 38.87B 28.22M Sales 2023 47.84B 34.73M Capitalization 75.04B 54.48M
Net income 2022 4.4B 3.2M Net income 2023 3.74B 2.71M EV / Sales 2022 1.13 x
Net cash position 2022 17.56B 12.75M Net cash position 2023 16.79B 12.19M EV / Sales 2023 1.22 x
P/E ratio 2022
13.8 x
P/E ratio 2023
20.7 x
Employees 236
Yield 2022 *
-
Yield 2023
-
Free-Float 28.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.25%
1 week-3.19%
Current month-8.54%
1 month-9.00%
3 months-11.36%
6 months-49.54%
Current year-16.13%
More quotes
1 week
2 610.00
Extreme 2610
2 785.00
1 month
2 610.00
Extreme 2610
3 175.00
Current year
2 610.00
Extreme 2610
3 475.00
1 year
2 610.00
Extreme 2610
9 750.00
3 years
2 370.00
Extreme 2370
9 750.00
5 years
2 370.00
Extreme 2370
9 750.00
10 years
2 370.00
Extreme 2370
9 750.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 55 -
Members of the board TitleAgeSince
Chief Executive Officer 56 -
Director/Board Member 43 -
Director of Finance/CFO 55 -
More insiders
Date Price Change Volume
24-04-22 2,730 +2.25% 73,565
24-04-19 2,670 -2.02% 143,254
24-04-18 2,725 +2.06% 100,573
24-04-17 2,670 +0.38% 50,484
24-04-16 2,660 -5.67% 288,200

End-of-day quote Korea S.E., April 21, 2024

More quotes
DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A223250 Stock